Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1995-05-25
1997-08-05
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514534, 514543, 514567, 514568, 514640, 514689, 514699, 514712, 514717, 514721, 560 11, 560 18, 560 35, 560 67, 562429, 562432, 562440, 562475, 564254, 564256, 564265, 564365, 564374, 568 33, 568 37, 568 52, 568331, 568442, 568644, 568645, A61K 31085, A61K 3110, A61K 3119, A61K 31235
Patent
active
056543310
ABSTRACT:
Diaromatic compounds, characterised in that they correspond to the following general formula: ##STR1## in which: R.sub.1 is --CH.sub.3, --CH.sub.2 OH, --COR.sub.8 or --CH.sub.2 OCOR.sub.9, R.sub.8 is H, OH, --OR.sub.10, --N(rr') or alkyl, R.sub.10 is alkyl, alkenyl, aryl or aralkyl, r and r' being H, alkyl, aryl, aralkyl, etc., r and r' together form a heterocycle, R.sub.9 is alkyl, alkenyl or a sugar residue, R.sub.2 and R.sub.3 are --OR.sub.11 or --OCOR.sub.11, R.sub.11 is H, alkyl, fluoroalkyl, aryl or aralkyl, R.sub.3 in addition being H, R.sub.4 is H, OH, alkyl, alkoxy, F, Cl or --CF.sub.3, R.sub.5 and R.sub.7 are H, OH, alkoxy, .alpha.-substituted alkyl or .alpha.,.alpha.'-disubstituted alkyl, etc., R.sub.6 is H, OH, alkyl, alkoxy, cycloalkyl, etc., R.sub.5 and R.sub.7 cannot simultaneously be OH or alkoxy and R.sub.4, R.sub.5, R.sub.6 and R.sub.7 cannot simultaneously be H, R.sub.5 and R.sub.6 or R.sub.6 and R.sub.7 can form, with the aromatic ring, a ring with 5 or 6 members, X is chosen from amongst:
REFERENCES:
patent: 4937371 (1990-06-01), Carson et al.
patent: 5191108 (1993-03-01), Carson et al.
Kucklaender et al., Chemical Abstract, vol. 109, abstract 149274. 1987.
Iwasaki et al., CApreviews, 94:553188 1994.
S. Strickland et al., "Structured-Activity Relationship of a New Series of Retinoidal Benzoic Acid Derivatives as Measured by Induction of Differentiation of Murine F9 Teratocarcinoma Cells and Human HL-60 Promyelocytic Leukemia Cells", Cancer Research, 43, pp. 5268-5272, Nov. 1983.
A.K. Verma et al., "Inhibition of 12-0-Tetradecanoylphorbol-13-acetate-induced Ornithine Decarboxylase Activity in Mouse Epidermis by Vitamin A Analogs (Retinoids)", Cancer Research, 38, pp. 793-801, Mar. 1978.
M.M. Goodman et al., "Human Keratinocyte X Hela Hybrids for Detection of Keratinocyte Differentiation-Specific Antigens", Models Dermatol., 1989, vol. 4, pp. 1-4.
J.M. Geiger et al., "Rat Vaginal Epithelium Assay for Screening Retinoids", Pharmacol Skin, 1989, vol. 3, pp. 141-143.
Carson et al., Chemcial Abstract, vol. III (1989) 153303.
CA previews, 94:553188 (1994).
Centre International De Recherches Dermatologiques Galderma (Cir
Raymond Richard L.
LandOfFree
Diaromatic compounds derived from a salicylic unit and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diaromatic compounds derived from a salicylic unit and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diaromatic compounds derived from a salicylic unit and their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1075189